Total oxidative stress and antioxidant status in patients with carpal tunnel syndrome

Figures & data

Table 1. Demographic characteristics

	Subjects with CTS (n:43)	Controls (n:43)	P value
Age (years)	43.30 ± 10.48 (23–65)	41.76 ± 9.92 (23–65)	>0.05
Gender	38 Female (88%), 5 male (12%)	36 Female (84%), 7 male (16%)	>0.05
Body mass index (kg/m^2)	29.10 ± 4.08 (20.06–37.46)	27.92 ± 3.46 (20.76–36.44)	>0.05

The age and BMI values represent the mean ± SD.

Table 2. Clinical and electromyographic findings in patients with CTS

	Patient (n:43, total 81 hands)
Symptom duration (months)	30.9 (5–67)
VAS (mm)	7.02 ± 1.16 (5–9)
Boston Questionnaire	41.81 ± 7.53 (29–60)
SSS	24.83 ± 4.85 (16–36)
FSS	17.20 ± 3.29 (9–26)
Right NCV	35.42 ± 11.03 (0–45.80)
Right motor latency	4.92 ± 1.49 (3.15–9.55)
Left NCV	36.74 ± 13.47 (0–57.00)
Left motor latency	4.63 ± 1.46 (3.15–10.35)

NCV, nerve conduction velocity.

The values except for symptom duration represent the mean ± SD.

Table 3. Serum total antioxidant status, total oxidative stress, and oxidative stress index values in patients with carpal tunnel syndrome

	Subjects with CTS (n:43) mean ± SD	Controls (n:43) mean ± SD	P value
TAS (mmol Trolox Eq/l)	1.01 ± 0.14 (0.62–1.33)	1.11 ± 0.20 (0.83–1.77)	0.008
TOS (μmol H2O2 Eq/l)	15.60 ± 7.03 (8.50–37.13)	11.86 ± 2.18 (8.36–17.20)	0.002
OSI (arbitrary unit)	1.57 ± 0.72 (0.84–3.67)	1.09 ± 0.28 (0.47–1.83)	<0.001

The values represent the mean ± SD.